Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01138085
Title Safety, Pharmacokinetics (PK) of AKT and MEK Combination
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Aurora Colorado 80045 United States Details
GSK Investigational Site New Haven Connecticut 06520 United States Details
GSK Investigational Site Boston Massachusetts 02114 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site New Brunswick New Jersey 08901 United States Details
GSK Investigational Site Nashville Tennessee 37232 United States Details
GSK Investigational Site Dallas Texas 75246 United States Details
GSK Investigational Site Houston Texas 77230-1439 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Salt Lake City Utah 84112-5550 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field